These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32516780)

  • 1. Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation.
    Xiao M; Zhang M; Bie M; Wang X; Guo J; Xiao H
    Cardiology; 2020; 145(7):446-455. PubMed ID: 32516780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of TGF-β1/α-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients.
    Shen H; Wang J; Min J; Xi W; Gao Y; Yin L; Yu Y; Liu K; Xiao J; Zhang YF; Wang ZN
    Cell Physiol Biochem; 2018; 47(2):851-863. PubMed ID: 29807358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
    Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
    Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Sox9 on TGF-β1-mediated atrial fibrosis.
    Wang H; Chen Y; Zhao S; Wang X; Lu K; Xiao H
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1450-1458. PubMed ID: 34596216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/smad2/3 signalling pathway.
    Hu HJ; Wang XH; Zhang ZZ; Ou Y; Ning ZH; Yang JY; Huang H; Tang HF; Jiang ZS
    Eur J Pharmacol; 2024 Nov; 982():176900. PubMed ID: 39168432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
    Cao F; Li Z; Ding WM; Yan L; Zhao QY
    Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-21 via Dysregulation of WW Domain-Containing Protein 1 Regulate Atrial Fibrosis in Atrial Fibrillation.
    Tao H; Zhang M; Yang JJ; Shi KH
    Heart Lung Circ; 2018 Jan; 27(1):104-113. PubMed ID: 28495464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease.
    Sun Y; Huang ZY; Wang ZH; Li CP; Meng XL; Zhang YJ; Su F; Ma N
    Mol Cell Biochem; 2015 Aug; 406(1-2):131-8. PubMed ID: 25971370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of MG53 in the regulation of transforming-growth-factor-β1-induced atrial fibrosis and vulnerability to atrial fibrillation.
    Guo J; Jia F; Jiang Y; Li Q; Yang Y; Xiao M; Xiao H
    Exp Cell Res; 2018 Jan; 362(2):436-443. PubMed ID: 29233682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
    He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
    Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation.
    Zhang M; Wang H; Wang X; Bie M; Lu K; Xiao H
    Cell Cycle; 2020 Oct; 19(20):2734-2744. PubMed ID: 33000676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.
    Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LICPAR regulates atrial fibrosis via TGF-β/Smad pathway in atrial fibrillation.
    Wang H; Song T; Zhao Y; Zhao J; Wang X; Fu X
    Tissue Cell; 2020 Dec; 67():101440. PubMed ID: 32971457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-499-5p inhibits transforming growth factor-β1-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGFβ-R1.
    Zhao Q; Yang W; Li X; Yuan H; Guo J; Wang Y; Shan Z
    Mol Biol Rep; 2023 Dec; 50(12):9757-9767. PubMed ID: 37676431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
    Rahmutula D; Zhang H; Wilson EE; Olgin JE
    Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.
    Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB
    Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease.
    Xiao H; Lei H; Qin S; Ma K; Wang X
    Clin Cardiol; 2010 Mar; 33(3):149-56. PubMed ID: 20235205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.